Stay updated on Patisiran for hATTR Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Patisiran for hATTR Amyloidosis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0; no visible changes to study content or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-03-20T03:43:54.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T19:02:10.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added the topic keyword 'Amyloidosis' and updated the page revision from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T00:02:04.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Minor version update from v3.4.0 to v3.4.1; no changes to core study content or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:53:57.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    UI updates include a Show glossary option and changes to metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'), with capitalization tweaks like 'No FEAR Act Data'. These are cosmetic changes that do not affect study content or eligibility information.
    Difference
    0.3%
    Check dated 2026-01-28T21:41:17.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 across the page. This appears to be a minor software revision with no changes to study details or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-01-14T04:24:45.000Z thumbnail image

Stay in the know with updates to Patisiran for hATTR Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.